Neogen Chemicals Board Meeting on Oct 31 to Approve Q2 Results & NCD Redemption

Neogen Chemicals Ltd has announced that its Board of Directors will convene on October 31, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Additionally, the board will evaluate and approve the proposal for the voluntary redemption of 20,000 secured, listed, rated, redeemable, non-cumulative, non-convertible debentures (NCDs) with a face value of ₹1,00,000 each, aggregating ₹200 Crores. These NCDs were issued on August 12, 2025. The trading window for dealing in the company's securities will remain closed from October 1, 2026, until 48 hours after the declaration of the financial results.